// App-Quantinova.ai

P514 : Optimising response to infliximab in the management of perianal Crohn’s disease

Researchers

Presenter

  • SHAH , R

Principal Investigators

  • Anandbaskaran , S

  • Hart , A

  • Tozer , P

Medical Centers

  • St Mark's Hospital- London North West Hospitals NHS Trust, Inflammatory Bowel Disease, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • C reactive protein

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • Infliximab

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved